Zhang Junzhe, Zhao Kuo, Li Junyong, Meng Hongyu, Zhu Yanbin, Zhang Yingze
Department of Orthopaedic Surgery, the Third Hospital of Hebei Medical University, No. 139 Ziqiang Road, Shijiazhuang, 050051, Hebei Province, People's Republic of China.
Key Laboratory of Biomechanics of Hebei Province, Orthopaedic Research Institution of Hebei Province, Shijiazhuang, Hebei Province, People's Republic of China.
J Orthop Surg Res. 2020 Nov 25;15(1):559. doi: 10.1186/s13018-020-02089-4.
In this study, we investigated the epidemiological characteristics and predictors of preoperative new-onset deep vein thrombosis (DVT) in adult patients with closed distal femur fractures (DFFs).
The study was designed as a prospective cohort trial at the Third Hospital of Hebei Medical University. From October 2018 to June 2020, a total of 160 patients with closed DFFs were enrolled to assess the location and prognosis of preoperative DVT. The patients were followed up for 2 months. Duplex ultrasonography (DUS) was used to diagnose patients with DVT. The patients were divided into two groups (DVT group and non-DVT group). The DVT was then classified into proximal, distal, and mixed thromboses. The Mann-Whitney U test or t test, receiver operating characteristic (ROC) analyses, univariate Chi-square analyses, and multiple logistic regression analyses were used to analyze the adjusted predictors of DVT.
The overall incidence of preoperative DVTs was 52.5% (n = 84), which was diagnosed at a mean period of 3.1 days after injury. Among patients diagnosed with DVTs, 50.0% (n = 42) had distal thrombosis while 47.6% (n = 40) had mixed thrombosis. The calf muscle veins were the most common sites of DVTs (90.5%, n = 76). Of note, 45.2% (n = 38) of diagnosed DVTs were completely recanalized at a mean period of 12.0 days after the initial (first) diagnosis. Multivariate analysis revealed that age of ≥ 65 years of age (odds ratio [OR], 4.390; 95% confidence interval [CI] 1.727-11.155; p = 0.002), C-reactive protein (CRP) levels exceeding 11 mg/L (OR 4.158; 95% CI 1.808-11.289; p = 0.001), platelet (PLT) levels over 217 × 109/L (OR, 2.55; 95% CI 1.07-6.07; p = 0.035), D-dimer levels over 1.0 mg/L (OR 3.496; 95% CI 1.483-8.237; p = 0.004), and an American Society of Anesthesiologists (ASA) score of III-V (OR 2.753; 95% CI 1.216-6.729; p = 0.026) were the independent risk factors of preoperative DVT.
High levels of CRP, PLT, D-dimer, ASA, and ≥ 65 years of age increase the risk of preoperative DVTs in adult patients with closed DFFs. Thus, the prediction of preoperative DVTs can significantly be improved by identifying older patients over the age of 65, and establishing the biochemical cut-off values of CRP, PLT, ASA, and D-dimer.
No. 2018-026-1, 24 October 2018, prospectively registered. This trial was registered prospectively on 24 October 2018 before the first participant was enrolled. This study protocol conformed to the Declaration of Helsinki and approved by the Institutional Review Board. The ethics committee approved the study on the factors of prognosis for patients with fractures. Data used in this study were obtained from the patients who underwent orthopedic surgery between October 2018 and June 2020.
在本研究中,我们调查了闭合性股骨远端骨折(DFF)成年患者术前新发深静脉血栓形成(DVT)的流行病学特征及预测因素。
本研究设计为河北医科大学第三医院的一项前瞻性队列试验。2018年10月至2020年6月,共纳入160例闭合性DFF患者,以评估术前DVT的部位及预后。对患者进行2个月的随访。采用双功超声(DUS)诊断DVT患者。将患者分为两组(DVT组和非DVT组)。然后将DVT分为近端、远端和混合性血栓形成。采用曼-惠特尼U检验或t检验、受试者工作特征(ROC)分析、单因素卡方分析和多因素逻辑回归分析来分析DVT的校正预测因素。
术前DVT的总体发生率为52.5%(n = 84),平均在受伤后3.1天被诊断出来。在诊断为DVT的患者中,50.0%(n = 42)为远端血栓形成,而47.6%(n = 40)为混合性血栓形成。小腿肌肉静脉是DVT最常见的部位(90.5%,n = 76)。值得注意的是,45.2%(n = 38)的诊断为DVT的患者在初次(首次)诊断后平均12.0天完全再通。多因素分析显示,年龄≥65岁(比值比[OR],4.390;95%置信区间[CI] 1.727 - 11.155;p = 0.002)、C反应蛋白(CRP)水平超过11 mg/L(OR 4.158;95% CI 1.808 - 11.289;p = 0.001)、血小板(PLT)水平超过217×10⁹/L(OR,2.55;95% CI 1.07 - 6.07;p = 0.035)、D-二聚体水平超过1.0 mg/L(OR 3.496;95% CI 1.483 - 8.237;p = 0.004)以及美国麻醉医师协会(ASA)评分III - V级(OR 2.753;95% CI 1.216 - 6.729;p = 0.026)是术前DVT的独立危险因素。
CRP、PLT、D-二聚体、ASA水平升高以及年龄≥65岁会增加闭合性DFF成年患者术前DVT的风险。因此,通过识别65岁以上的老年患者并确定CRP、PLT、ASA和D-二聚体的生化临界值,可显著改善术前DVT的预测。
2018年10月24日,注册号2018 - 026 - 1,前瞻性注册。本试验在2018年10月24日第一位参与者入组前进行前瞻性注册。本研究方案符合《赫尔辛基宣言》,并获得机构审查委员会批准。伦理委员会批准了关于骨折患者预后因素的研究。本研究中使用的数据来自2018年10月至2020年6月接受骨科手术的患者。